← Open Payments lookup

CHELSEA CLEMENS: Open Payments

NPI 1104300987 · STAMFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,792 in 87 payments from 14 companies in 2025. Trend: 2023 $3,302 · 2024 $2,337 · 2025 $1,792

Food & beverage: $1,792
CompanyPaymentsAmount
CSL Behring14$295
AstraZeneca Pharmaceuticals LP10$202
GENZYME CORPORATION10$199
Novartis Pharmaceuticals Corporation9$190
Regeneron Healthcare Solutions, Inc.9$173
Takeda Pharmaceuticals U.S.A., Inc.8$160
Genentech USA, Inc.7$150
Amgen Inc.4$96
GlaxoSmithKline, LLC.5$89
ABBVIE INC.3$76

Products named: DUPIXENT, Xolair, Andembry, TEZSPIRE, FASENRA, HYQVIA, Haegarda, NUCALA.

Industry payments across CT — which companies pay providers there.